136 related articles for article (PubMed ID: 37125473)
1. Current elimination status of hepatitis C virus-infected maintenance hemodialysis patients in Iwate Prefecture, Japan.
Miyasaka A; Yoshida Y; Suzuki A; Endo K; Kakisaka K; Oikawa T; Abe T; Obara W; Matsumoto T
Ther Apher Dial; 2023 Oct; 27(5):848-854. PubMed ID: 37125473
[TBL] [Abstract][Full Text] [Related]
2. Occult hepatitis C virus infection in hemodialysis patients who achieved a sustained virological response to directly acting antiviral drugs: is it a concern?
Naguib H; Abouelnaga SF; Elsayed MM
Int Urol Nephrol; 2024 Jan; 56(1):217-222. PubMed ID: 37209238
[TBL] [Abstract][Full Text] [Related]
3. Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study.
Kikuchi K; Akiba T; Nitta K; Masakane I; Ando R; Izumi N; Atsukawa M; Yamazaki C; Kato F; Hotta N; Tominaga Y; Orito E; Hora K; Nagasawa M; Kasahara H; Kawaguchi M; Kimura H; Ikebe N; Kawanishi H; Moriishi M; Shigemoto K; Harada T; Hirakata H; Watanabe H; Nosaki T; Tsubouchi H; Imawari M; Akizawa T
Ther Apher Dial; 2014 Dec; 18(6):603-11. PubMed ID: 25196061
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological Survey of Patients With Hemodialysis Complicated by Hepatitis C in Japan.
Okubo T; Atsukawa M; Tsubota A; Koeda M; Yoshida Y; Arai T; Nakagawa-Iwashita A; Itokawa N; Kondo C; Fujimori S; Tsuruoka S; Iwakiri K
Ther Apher Dial; 2019 Feb; 23(1):44-48. PubMed ID: 30125469
[TBL] [Abstract][Full Text] [Related]
5. Virological responses of pegylated interferon alpha-2a treatment in hemodialysis patients infected with hepatitis C.
Köse Ş; Senger SS; Ersan G; Çavdar G
Clin Exp Nephrol; 2013 Feb; 17(1):115-9. PubMed ID: 22814955
[TBL] [Abstract][Full Text] [Related]
6. Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co-infection.
Lodi S; Klein M; Rauch A; Epstein R; Wittkop L; Logan R; Rentsch CT; Justice AC; Touloumi G; Berenguer J; Jarrin I; Egger M; Puoti M; D'Arminio Monforte A; Gill J; Salmon Ceron D; van Sighem A; Linas B; van der Valk M; Hernán MA;
J Int AIDS Soc; 2022 Dec; 25(12):e26048. PubMed ID: 36562643
[TBL] [Abstract][Full Text] [Related]
7. Lack of hepatitis C virus reinfection in lifetime of Japanese general population with previous hepatitis C virus (HCV) infection successfully treated with anti-HCV therapy.
Toyoda H; Yasuda S; Shiota S; Kumada T; Tanaka J
J Infect Chemother; 2021 Nov; 27(11):1674-1675. PubMed ID: 34419353
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
Campistol JM; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva JA; Costa J; Barrera JM; Bruguera M
Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
[TBL] [Abstract][Full Text] [Related]
9. Misunderstanding of hepatitis C virus (HCV) infection status by non-specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy.
Toyoda H; Yasuda S; Moriya A; Itobayashi E; Uojima H; Watanabe T; Atsukawa M; Arai T; Ishikawa T; Mikami S; Hiraoka A; Tsuji K; Oikawa T; Tsubota A; Nozaki A; Chuma M; Abe H; Shima T; Kumada T; Tanaka J
J Infect Chemother; 2022 Sep; 28(9):1231-1234. PubMed ID: 35534339
[TBL] [Abstract][Full Text] [Related]
10. Detection of Occult Hepatitis C Virus Infection in Egyptian Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents.
Mashaal AR; Abd El-Hameed M; El Ray AA; Mahmoud Diab T; Dawood RM; Shemis MA; Seyam M
Asian Pac J Cancer Prev; 2022 Sep; 23(9):2965-2971. PubMed ID: 36172658
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow up of sustained viral response after treatment of hepatitis C with pegylated interferon alpha-2a in hemodialysis patients.
Dzekova P; Asani A; Selim G; Gelev S; Trajceska L; Amitov V; Selja N; Zabzun M; Mena S; Gaseva M; Sikole A
Int J Artif Organs; 2009 Mar; 32(3):180-4. PubMed ID: 19440994
[TBL] [Abstract][Full Text] [Related]
12. Antiviral treatment and prognosis in patients undergoing maintenance hemodialysis due to hepatitis C virus.
Zhang W; Yuan Q; Ning J; Li X; Wu A; Xiao X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1332-1337. PubMed ID: 35232901
[TBL] [Abstract][Full Text] [Related]
13. The care cascade for hepatitis C virus and prognosis of chronic hepatitis C patients treated with antiviral agents in a tertiary hospital.
Yoo SH; Kim M; Kim S; Lee JI; Lee KS; Lee HW; Lim JH
BMC Gastroenterol; 2023 Apr; 23(1):116. PubMed ID: 37041473
[TBL] [Abstract][Full Text] [Related]
14. HCV elimination in a Swiss opioid agonist therapy programme - a cohort study.
Bregenzer A; Krismer C; Wendel S; Roser P; Fux CA
Swiss Med Wkly; 2022 Dec; 152():40009. PubMed ID: 36509421
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of hepatitis C antiviral treatment and feasibility of hepatitis C elimination goal.
Burgui C; San Miguel R; Goñi-Esarte S; Juanbeltz R; Úriz-Otano JI; Reparaz J; Sarobe M; Zozaya JM; Castilla J
Postgrad Med; 2023 May; 135(4):352-360. PubMed ID: 36305320
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of liver from hepatitis C-infected donors to hepatitis C RNA-negative recipients: Histological and virologic outcome.
Nair SP; Marella HK; Maliakkal B; Snyder H; Handley C; Kothadia JP; Ali B; Satapathy SK; Molnar MZ; Clark I; Jain R; Helmick R; Eymard C; Eason JD
Clin Transplant; 2021 May; 35(5):e14281. PubMed ID: 33690929
[TBL] [Abstract][Full Text] [Related]
17. Is early virological response as predictive of the hepatitis C treatment response in dialysis patients as in non-uremic patients?
Fucuta Pereira Pda S; Uehara SN; de Mello Perez R; Feldner AC; de Melo IC; de Souza e Silva IS; Silva AE; Ferraz ML
Int J Infect Dis; 2013 Jan; 17(1):e50-3. PubMed ID: 23041364
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic hepatitis C in Asia: when East meets West.
Yu ML; Chuang WL
J Gastroenterol Hepatol; 2009 Mar; 24(3):336-45. PubMed ID: 19335784
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis C virus infection among men who have sex with men with human immunodeficiency virus-1 infection between 2010 and 2020 in Japan: A single-center retrospective cohort study.
Nishikawa K; Kimura M; Imamura J; Kimura K
J Infect Chemother; 2023 Mar; 29(3):263-268. PubMed ID: 36585274
[TBL] [Abstract][Full Text] [Related]
20. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
Martin-Carbonero L; Nuñez M; Mariño A; Alcocer F; Bonet L; García-Samaniego J; López-Serrano P; Cordero M; Portu J; Soriano V
AIDS; 2008 Jan; 22(1):15-21. PubMed ID: 18090387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
